Drug research

Adalimumab

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis SuppurativaNCT05322473	MoonLake Immunotherapeutics AG	Phase 2	Completed	2023-05-09Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisNCT05640245	MoonLake Immunotherapeutics AG	Phase 2	Completed	2023-09-05Actual

MoonLake Immunotherapeutics AGCompletedPrimary completion: 2023-05-09 · Actual

Trial details

MoonLake Immunotherapeutics AGCompletedPrimary completion: 2023-09-05 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.